198 related articles for article (PubMed ID: 21951695)
61. Characterization of the immunogenicity of formaldehyde detoxified Pasteurella multocida toxin.
Bording A; Foged NT
Vet Microbiol; 1991 Nov; 29(3-4):267-80. PubMed ID: 1771750
[TBL] [Abstract][Full Text] [Related]
62. Mammalian target of rapamycin complex 1 (mTORC1) plays a role in Pasteurella multocida toxin (PMT)-induced protein synthesis and proliferation in Swiss 3T3 cells.
Oubrahim H; Wong A; Wilson BA; Chock PB
J Biol Chem; 2013 Jan; 288(4):2805-15. PubMed ID: 23223576
[TBL] [Abstract][Full Text] [Related]
63. Activation of G
Ebner JK; König GM; Kostenis E; Siegert P; Aktories K; Orth JHC
Bone; 2019 Oct; 127():592-601. PubMed ID: 31376533
[TBL] [Abstract][Full Text] [Related]
64. Intranasal vaccination of New Zealand white rabbits against pasteurellosis, using alginate-encapsulated Pasteurella multocida toxin and potassium thiocyanate extract.
Jarvinen LZ; HogenEsch H; Suckow MA; Bowersock TL
Comp Med; 2000 Jun; 50(3):263-9. PubMed ID: 10894489
[TBL] [Abstract][Full Text] [Related]
65. Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts.
Gwaltney SM; Galvin RJ; Register KB; Rimler RB; Ackermann MR
Vet Pathol; 1997 Sep; 34(5):421-30. PubMed ID: 9381653
[TBL] [Abstract][Full Text] [Related]
66. Pasteurella multocida toxin activates Gbetagamma dimers of heterotrimeric G proteins.
Preuss I; Kurig B; Nürnberg B; Orth JH; Aktories K
Cell Signal; 2009 Apr; 21(4):551-8. PubMed ID: 19135527
[TBL] [Abstract][Full Text] [Related]
67. Pasteurella multocida toxin: the mitogenic toxin that stimulates signalling cascades to regulate growth and differentiation.
Lax AJ; Grigoriadis AE
Int J Med Microbiol; 2001 Sep; 291(4):261-8. PubMed ID: 11680786
[TBL] [Abstract][Full Text] [Related]
68. Two Bordetella bronchiseptica attenuated vaccine candidates confer protection against lethal challenge with B. Bronchiseptica and Pasteurella multocida toxin in mouse models.
Zhang Y; Lin L; Yang J; Lv Q; Wang M; Wang F; Huang X; Hua L; Wang X; Chen H; Wilson BA; Wu B; Peng Z
Vaccine; 2022 Jun; 40(27):3771-3780. PubMed ID: 35599036
[TBL] [Abstract][Full Text] [Related]
69. [The detection of Pasteurella multocida toxin using a commercially available ELISA].
Weber A; Wachowitz R; Singer H; Heil-Franke G
Berl Munch Tierarztl Wochenschr; 1993 Oct; 106(10):328-30. PubMed ID: 8250823
[TBL] [Abstract][Full Text] [Related]
70. Pasteurella multocida toxin is a potent inducer of anchorage-independent cell growth.
Higgins TE; Murphy AC; Staddon JM; Lax AJ; Rozengurt E
Proc Natl Acad Sci U S A; 1992 May; 89(10):4240-4. PubMed ID: 1584759
[TBL] [Abstract][Full Text] [Related]
71. Detection of stable epitopes on formaldehyde-detoxified Pasteurella multocida toxin by monoclonal antibodies.
Foged NT
Vaccine; 1991 Nov; 9(11):817-24. PubMed ID: 1722064
[TBL] [Abstract][Full Text] [Related]
72. Pasteurella multocida toxin (PMT) activates RhoGTPases, induces actin polymerization and inhibits migration of human dendritic cells, but does not influence macropinocytosis.
Blöcker D; Berod L; Fluhr JW; Orth J; Idzko M; Aktories K; Norgauer J
Int Immunol; 2006 Mar; 18(3):459-64. PubMed ID: 16415096
[TBL] [Abstract][Full Text] [Related]
73. Involvement of Osteocytes in the Action of
Heni H; Ebner JK; Schmidt G; Aktories K; Orth JHC
Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30104531
[No Abstract] [Full Text] [Related]
74. A systemic Pasteurella multocida toxin aggravates cardiac hypertrophy and fibrosis in mice.
Weise M; Vettel C; Spiger K; Gilsbach R; Hein L; Lorenz K; Wieland T; Aktories K; Orth JH
Cell Microbiol; 2015 Sep; 17(9):1320-31. PubMed ID: 25759205
[TBL] [Abstract][Full Text] [Related]
75. Characterization of toxin from different strains of Pasteurella multocida serotype A and D.
Frandsen PL; Foged NT; Petersen SK; Bording A
Zentralbl Veterinarmed B; 1991 Jul; 38(5):345-52. PubMed ID: 1927149
[TBL] [Abstract][Full Text] [Related]
76. Pasteurella multocida Toxin-induced Pim-1 expression disrupts suppressor of cytokine signalling (SOCS)-1 activity.
Hildebrand D; Walker P; Dalpke A; Heeg K; Kubatzky KF
Cell Microbiol; 2010 Dec; 12(12):1732-45. PubMed ID: 20633028
[TBL] [Abstract][Full Text] [Related]
77. Pasteurella multocida toxin activates various heterotrimeric G proteins by deamidation.
Orth JH; Aktories K
Toxins (Basel); 2010 Feb; 2(2):205-14. PubMed ID: 22069582
[TBL] [Abstract][Full Text] [Related]
78. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue.
Ward PN; Miles AJ; Sumner IG; Thomas LH; Lax AJ
Infect Immun; 1998 Dec; 66(12):5636-42. PubMed ID: 9826336
[TBL] [Abstract][Full Text] [Related]
79. IFN-γ promotes PANoptosis in Pasteurella multocida toxin-induced pneumonia in mice.
Xiao H; Zhao Q; Yuan J; Liang W; Wu R; Wen Y; Du S; Wang Y; Zhao S; Lang Y; Yan Q; Huang X; Cao S
Vet Microbiol; 2023 Oct; 285():109848. PubMed ID: 37722207
[TBL] [Abstract][Full Text] [Related]
80. Protective immunity to Pasteurella multocida heat-labile toxin by intranasal immunization in rabbits.
Suckow MA; Bowersock TL; Nielsen K; Chrisp CE; Frandsen PL; Janovitz EB
Lab Anim Sci; 1995 Oct; 45(5):526-32. PubMed ID: 8569151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
